FIVE THINGS TO KNOW ABOUT...Diabetic retinopathy
- Juvenile diabetes eye complications and treatment. Dujic, Mirjana P.; Ignjatovic, Zora // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Sep2009, Vol. 66 Issue 9, p729
Background/Aim. Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia. The aim of this study was to explore the prognosis of patients with juvenile DM regarding diabetic eye complications, as well as the course of the diabetic eye disease related to the treatment...
- Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. Rohan, Thomas E.; Frost, Christopher D.; Wald, Nicholas J. // BMJ: British Medical Journal (International Edition);11/11/89, Vol. 299 Issue 6709, p1198
Assesses the prevention of blindness by screening for diabetic retinopathy. Administration of laser photocoagulation of the retina; Details on the reduction of blindness; Prevention on the deterioration of visual acuity.
- Diabetic Retinopathy: Understanding Pathologic Angiogenesis and Exploring its Treatment Options. Falcão, Manuel; Falcão-Reis, Fernando; Rocha-Sousa, Amândio // Open Circulation & Vascular Journal;2010 Special Issue, p30
Diabetic retinopathy is the major cause of blindness at working age. The pathogenesis behind visual loss is related with retinal angiogenesis and increased retinal vascular permeability. These changes seem to be the result of chronic hyperglycemia and hypoxia. Several mechanisms have been...
- Erratum to: Comparison of microincision vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy. Yokota, Reiji; Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Hirota, Kazunari; Hirakata, Akito // Japanese Journal of Ophthalmology;Nov2015, Vol. 59 Issue 6, p436
A correction to the article "Comparison of microincision vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy" that was published online on September 8, 2015 is presented.
- Diabetic Retinopathy. // Clinical Diabetes;Winter 2001, Vol. 19 Issue 1, p29
Presents American Diabetes Association's position statement on diabetic retinopathy. Vascular complication of both type 1 and type 2 diabetes; Natural history of diabetic retinopathy; Screening strategies; Efficacy of laser photocoagulation surgery; Cost-effectiveness of screening for retinopathy.
- The Role of Oxidative Stress after Retinal Laser Photocoagulation in Nonproliferative Diabetic Retinopathy. Galetović, Davor; Bojić, Lovro; Bućan, Kajo; Karlica, Dobrila; Lešin, Mladen; Znaor, Ljubo // Collegium Antropologicum;Sep2011, Vol. 35 Issue 3, p835
Diabetic retinopathy (DR) represents the most common chronic complication of diabetes, and it is the leading cause of new cases of blindness in patients between 20-74 years old in developed countries. Laser photocoagulation (LF) represents an efficacious approach to the treatment of DR....
- Diabetic retinopathy: A clinical update M. Porta et al.: Diabetic retinopathy. Porta, M.; Bandello, F. // Diabetologia;Dec2002, Vol. 45 Issue 12, p1617
Easy observation of the fundus oculi makes retinopathy the most frequently reported chronic complication of diabetes and, consequently, the one we know best in terms of epidemiology and natural history. Achieving near-normal levels of blood glucose and blood pressure provides empirical though...
- Role of Cytokines and Trophic Factors in the Pathogenesis of Diabetic Retinopathy. Mitamura, Yoshinori; Harada, Chikako; Harada, Takayuki // Current Diabetes Reviews;2005, Vol. 1 Issue 1, p73
Diabetic retinopathy (DR) is one of the most frequent complications of diabetes and the leading cause of acquired blindness in developed countries. A note worthy problem in DR is the formation of fibrovascular epiretinal membranes (ERMs) which can cause tractional retinal detachment in the...
- Risk factors and diabetic retinopathy. Dizdarević, Admira; Alikadić-Husović, Amila; Jusufović, Vahid // Medicinski Glasnik;Feb2012, Vol. 9 Issue 1, p104
The aim of the study was to determine the correlation between risk factors and diabetic retinopathy, which is the leading cause of blindness in developed countries for patients aged 20 to 65. We compared risk factors between patients without retinopathy, with non-proliferate and with proliferate...